Toho Holdings Co., Ltd. (TYO:8129)
Japan
· Delayed Price · Currency is JPY 4,851.00
+28.00 (0.58%)
Mar 10, 2026, 1:15 PM JST
Toho Holdings Revenue
Toho Holdings had revenue of 415.26B JPY in the quarter ending December 31, 2025, with 2.01% growth. This brings the company's revenue in the last twelve months to 1.54T, up 1.34% year-over-year. In the fiscal year ending March 31, 2025, Toho Holdings had annual revenue of 1.52T with 2.83% growth.
Revenue (ttm)
1,539.60B
Revenue Growth
+1.34%
P/S Ratio
0.20
Revenue / Employee
202.34M
Employees
7,609
Market Cap
312.06B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1,518.50B | 41.78B | 2.83% |
| Mar 31, 2024 | 1,476.71B | 88.15B | 6.35% |
| Mar 31, 2023 | 1,388.57B | 122.39B | 9.67% |
| Mar 31, 2022 | 1,266.17B | 55.90B | 4.62% |
| Mar 31, 2021 | 1,210.27B | -53.43B | -4.23% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nippon Shinyaku | 166.05B |
| Tsumura & Co. | 189.50B |
| Sawai Group Holdings | 200.68B |
| Hisamitsu Pharmaceutical Co. | 159.27B |
| Towa Pharmaceutical | 269.92B |
| Kissei Pharmaceutical | 95.29B |
| Kaken Pharmaceutical | 75.66B |
| Mochida Pharmaceutical | 111.92B |